Medline Inc.
Medline Inc. (MDLN) Stock Overview
Explore Medline Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
33.9B
P/E Ratio
29.35
EPS (TTM)
$1.43
ROE
0.08%
MDLN Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Medline Inc. (MDLN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 34.21, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $150.26.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 29.35 and a market capitalization of 33.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.